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Abstract. 
Background: The purpose of this study was to explore Twist expression in nasopharyngeal 
carcinoma and to investigate the prognostic impact of Twist expression on survival rates in 
patients with nasopharyngeal carcinoma. 
Methods: We utilized Western blotting to investigate the expression of Twist, vimentin, and 
E-cadherin in NPC cell lines. Additionally, a retrospective review of case notes from the Dalin 
Tzu Chi General Hospital archives was performed. We analyzed the relationship between 
Twist expression of tissue specimen, TNM staging, and survival rates by using immunohisto-
chemical staining. All nasopharyngeal carcinoma patients were included. We used Pearson’s 
chi-square and Fisher’s exact tests to analyze the correlation between Twist expression of tis-
sue specimen and TNM staging and clinical features. Kaplan-Meier survival curves were con-
structed and survival analysis was completed using Cox proportional hazard models. Receiver 
operating characteristic (ROC) curve was also examined in order to validate the ability of 
Twist expression to predict outcomes.  
Results: A total of 48 patients with newly diagnosed NPC were enrolled in this study. Nine-
teen patients (40%) in this series were found to have Twist overexpression. Twist overexpres-
sion in NPC patients was associated with pre-vertebral space invasion (P = 0.032). Patients 
with Twist overexpression were found to have a poor overall survival rate compared with oth-
ers (P = 0.01, respectively), but not metastasis free-survival rate (P = 0.126). There was a 
trend toward significance between Twist expression and advanced T classification (P = 0.094 
respectively). Multivariate analysis showed that Twist overexpression was associated with 
poor survival rate (hazard ratio 5, 95% confidence interval 1.07-27; P = 0.041). The receiver 
operating characteristic (ROC) curves for predicting outcomes revealed that Twist expression 
(area under curve = 0.735) was superior to T classification (area under curve = 0.718) and 
clinical stage (area under curve = 0.598). 
Conclusions: Twist may be a useful molecular marker for nasopharyngeal carcinoma and in-
dicator for overall survival. Patients with Twist expression should be treated more aggres-
sively. 
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原著論文  
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中文摘要 
背景：本文主要研究 Twist 在鼻咽癌患者體內的表現，並更深入的去探討 Twist 的表現，
對於鼻咽癌病患存活率的影響。 
方法：本文以回溯性的方法，收集所有大林慈濟醫院裡鼻咽癌的病患共 48 名。以免疫染
色的方法，去探討 Twist 在組織中的表現，與 TNM 分期及存活率之間的關係。並使用
Pearson的卡方Fisher的精確檢驗來分析Twist、TNM分期與臨床症狀的關聯。Kaplan-Meier
存活分析以及 Cox 比例風險模型來完整的評估存活率。Receiver operating characteristic 曲
線也受到審查，以驗證 Twist 表達能力進行預測的結果。 
結果：48 名鼻咽癌病患中，有 19 名(40%) 患者發生 Twist 過度表現。而 Twist 過度表現
與鼻咽癌病患脊椎前侵犯有明顯的關係( P 值是 0.032)。我們發現 Twist 過度表現對於整
體的生存率有明顯的不良影響( P 值是 0.01)。多因素分析也顯示 Twist 過度表現，與生存
率降低有關( hazard ratio 是 5, 95% confidence interval 是 1.07-27; P值是 0.041)。而 receiver 
operating characteristic (ROC)曲線在預測結果上面，也顯示 Twist過度表達(area under curve
是 0.735)，比T的腫瘤分期( area under curve是 0.718)及臨床分期( area under curve是 0.598)
還要來的重要。 
結論：Twist 在分子生物醫學上，或許是一個很好的標記工具。對於鼻咽癌的病患，從整
體的生存率上有統計學上的意義。因此，對於 Twist 過度表現的患者，或許應考慮給予更
積極的治療計畫。 
 
關鍵字: 鼻咽癌、Twist、生存率 
 
INTRODUCTION 
Taiwan is one of those areas with a high incidence 
of nasopharyngeal carcinoma (NPC): the annual inci-
dence rate is 6.17 per 100,000 as compared with <1 
per 100,000 in Western countries [1]. Treatment for 
patients with non-metastatic NPC has relied primarily 
on radiotherapy or concurrent chemoradiotherapy 
(CCRT), partly because of the inaccessibility of the 
anatomic site and the tumor’s high sensitivity to radi-
otherapy and chemotherapy. Numerous systems have 
been used to classify NPC in studies throughout the 
world. The most widely used systems are those of the 
American Joint Committee of Cancer (AJCC) and the 
International Union Against Cancer (UICC). However, 
the widely used tumor node metastasis (TNM) staging 
system does not allow for prediction of accurate 
prognosis. Reliable prognostic factors for NPC con-
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tinue to be sought to identify high-risk groups.  
Primary tumor volume, prevertebral space inva-
sion, and parapharyngeal involvement in NPC are sig-
nificant prognostic factors in multivariate analysis 
[2-4]. Besides these factors defined by image or clini-
cal finding, the molecular mechanism involved in car-
cinogenesis, tumor invasion, and apoptosis may con-
tribute to the pathogenesis and progression of cancer.  
Twist protein, a highly conserved basic helix- 
loop-helix protein, is essential for early embryogene-
sis and epithelial-mesenchymal transition [5,6]. Twist 
is associated with invasion and metastasis in breast 
cancer, esophageal cancer, hepatocellular carcinoma, 
and head and neck cancer [7-10]. It can induce    
Table 1. Patient characteristics categorized by Twist expression (n=48) 
 No. of patients 
(%) 
Twist negative No. 
(%) 
Twist Positive No. 
(%) 
P value 
All patient 48 29 (60) 19 (40)  
Age (years)    0.499 
 Median 49 52 48  
 Range 29-73 32-73 29-73  
Gender    0.099 
 Male 36 (75) 20 (69) 16 (84)  
 Female 12 (25) 9 (31) 3 (16)  
Stage    0.223 
 I-II 13 (27) 9 (31) 4 (21)  
 III-IV 35 (73) 20 (69) 15 (79)  
T stage    0.094 
 T1-2 33 (69) 22 (76) 11 (58)  
 T3-4 15 (31) 7 (24) 8 (42)  
N stage    0.328 
 N0-1 22 (46) 14 (48) 8 (42)  
 N2-3 26 (54) 15 (52) 11 (58)  
Prevertebral space invasion    0.032 
 Negative 28 (58) 20 (69) 8 (42)  
 Positive 20 (42) 9 (31) 11 (58)  
Histology    0.898 
 WHO I 4 (8) 2 (7) 2 (10)  
 WHO II 29 (60) 18 (62) 11 (58)  
 WHO III 15 (32) 9 (31) 6 (32)  
Treatment modality    0.427 
 RT/CRT 27 (56) 16 (55) 11 (58)  
 CCRT+CT 21 (54) 13 (45) 8 (42)  
Values in parenthese are expressed in percentage 
WHO. World Health Organization; RT, radiotherapy; CCRT, concurrent chemoradiotherapy; CCRT+CT, concurrent chemoradio-
therapy with adjuvant  
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epithelial-mensenchymal transition, which plays an 
essential role in tumor metastasis. It can induce the 
expression of Vimentin, and N-cadherin and reduce 
the expression of E-cadherin, and fibronectin, which 
may promote tumor migration and invasion of tumor 
cells [11,12]. The present study was designed to ana-
lyze the expression of Twist protein in NPC tissues by 
immunohistochemistry. Furthermore, we evaluated 
the clinicopathological association of Twist expres-
sion in patients with NPC and its impact on survival 
rates.  
 
MATERIALS AND METHODS 
 
Ethical Considerations 
The study was conducted with the approval of the 
human research ethics committees of our institution 
(IRB B09704028). All patient medical records were 
reviewed retrospectively, with anonymous evaluation 
of data. The study protocol conformed to ethical 
standards according to the Declaration of Helsinki 
published in 1964 in its actual version. 
 
Cell Cultures 
Three well-differentiated NPC cell lines, Tw-01 
Tw-04, and HONE-1 were maintained in our labora-
tory. All NPC cell lines were maintained in RPMI 
1640 medium supplemented with 10% fetal calf se-
rum. 
Western Blotting Analysis 
Cell lysates were prepared with a SDS lysis solu-
tion. Equal amounts of protein (50 μg) were separated 
by electrophoresis on a 12% SDS-polyacrylamide gel. 
The membrane was then incubated with primary anti-
bodies for 0.5-1 hr at room temperature against Twist 
(H-81; Santa Cruz Biotechnology, Santa Cruz, CA, 
USA), Vimentin (V-6630; Sigma, MO), E-cadherin 
(G-10; Santa Cruz Biotechnology, Santa Cruz, CA ), 
and GAPDH (MAB374; Chemicon (Millipore), 
Billerica, MA, USA ), respectively. After washing 
with TBS-T, the membrane was incubated with a 
secondary antibody against goat immunoglobulin G or 
mouse immunoglobulin G. The membrane was 
washed and detected by the enhanced chemilumines-
cence detection system (Amersham, Piscataway, NJ, 
USA). 
 
Participants 
Patients with a diagnosis of NPC from 2002 - 
2006 were identified from the cancer registry of our 
institute. Information from seventy-five patients was 
identified and retrieved from the archives. Twenty- 
seven patients were excluded because of the presence 
of distant metastasis at the time of presentation, and 
those patients lost to follow-up before course of 
treatment was completed. Patients were staged ac-
cording to the AJCC stage classification modified in 
2002. 
Table 2. Patient characteristics categorized by T and N classification 
 T classification 
Total 
T1 T2 T3 T4 
N classification   
N0 2 5 2 2 11
N1 2 6 2 1 11
N2 6 5 3 2 16
N3 3 4 2 1 10
Total 13 20 9 6 48
M. S. Lee et al./JCRP 1(2014) 186-196 189
All patients received a complete course of radio-
therapy with a radiation dosage of 70 Gy to 75 Gy. 
Concurrent chemoradiation (CCRT) was also pre-
scribed for 21 patients. These patients received 3 cy-
cles of cisplatin and 5-fluorouracil during radiotherapy. 
All patients were assessed by nasopharyngoscope at 
intervals of 10-15 weeks after the completion of radi-
otherapy. During regular follow-up, our examinations 
included physical and nasopharyngoscopic examina-
tions. Additionally, chest X-rays, abdominal sonogra-
phy, whole-body bone scans and body CT scans were 
performed regularly. 
 
Imnuno-histochemical Analysis 
Immunohistochemical staining using Dako 
LSAB+ System-HRP kit (Dako Corporation, Den-
mark) system was performed to study Twist expres-
sion in 48 human NPC tissues. A paraffin section of 
NPC tissue from each patient was deparaffinized with 
xylene and rehydrated later. The section was further 
submerged into citrate antigenic retrieval buffer and 
was heated using a microwave oven. Then, 3% hy-
drogen peroxide in methanol was added to terminate 
the endogenous peroxidase activity. After getting 
washed in 1% BSA, the rabbit polyclonal anti-Twist 
(H-81) antibody (Santa Cruz Biotechnology, San Di-
ego, CA, USA) was applied at a 1:100 dilution for 
overnight incubation at 4℃. Then the slides were in-
cubated at room temperature with LSAB+ kit, and 
subsequently reacted with diaminobenzidine (DAB) as 
a chromogen substrate. Negative controls were per-
formed by omitting the primary antibody. Two inde-
pendent observers made the interpretation of Twist 
protein expression. The staining intensity was scored 
as 0 (negative), 1(1+), 2 (2+) or 3 (3+), and the per-
centage of positive cells as 0 (0%), 1(<25%), 2 
(25-50%), 3 (>50%). When the value of percentage 
positive score multiplied by intensity score was >3, 
the case was interpreted as positive.  
 
Statistical Analysis 
All data were analyzed with the SPSS system. The 
association between different categorical variables 
was analyzed with Pearson’s chi-square test or Fish-
er’s exact test. Survival rates of the different Twist 
expression were compared using Kaplan-Meier esti-
mates and log-rank test for equality of survival curves. 
Survival was measured from the time of the first ap-
pointment by using overall death and recurrence as 
censoring variables. The Cox proportional regression 
model was used to evaluate the effect of Twist expres-
sion on survival rates after adjusting other potential 
prognostic factors. Receiver operating characteristic 
curve (ROC) was also examined to validate the ability 
of Twist overexpression to predict outcomes. 
 
RESULTS 
 
Expression of Twist Protein in Human 
Nasopharyngeal Cancer Cell Lines 
Western blotting analysis showed that Twist pro-
tein was highly expressed in the three NPC cell lines 
(Figure 1). Twist protein was associated with vimentin, 
mensenchymal marker, overexpression and downreg-
ulation of E-cadherin, and epithelial marker. The 
phenomenon of epithelial-mensenchymal transition  
Table 3. Comparison of expression of TWIST in distant metastasis and mortality (n=48) 
 Distant metastasis (%) P-value Death (%) P-value 
Twist 0.130  0.009
 Positive (n=19) 3(15.8) 7(36.8) 
 Negative (n=29) 1(3.4) 2(6.9) 
190 M. S. Lee et al./JCRP 1(2014) 186-196
 
 
 
 
 
 
 
 
 
Figure 1. Expression of Twist protein examined by 
Western blotting was associated with Vi-
mentin expression and downregulation of 
E-cadherin in three NPC cell lines 
 
 
was validated in the NPC cell lines with Twist expres-
sion. 
 
Participants 
The immunohistochemical staining of Twist pro-
tein was shown in Figure 2. This series included 48 
NPC patients. Four (8%) patients had keratinizing 
carcinoma, and 44 (92%) patients had non-keratinizing 
or undifferentiated carcinoma. The median age was 49 
years (range: 29-73 years), and 36 (75%) patients 
were men and 12 (25%) patients were women. The 
comparison of patient characteristics, TNM classifica-
tion, clinical presentations and expression of Twist 
were listed in Table 1. A significantly higher propor-
tion of patients with positive Twist protein expression 
were associated with prevertebral space invasion. 
There was a trend toward significance between Twist 
expression and advanced T classification upon initial 
diagnosis (P=0.094, respectively). There was no asso-
ciation between clinical stage, N classification, World 
Health Organization histological grade, and Twist 
expression. Patient characteristics were simply de-
scribed by T and N classification and listed in Table 2. 
 
Outcome Measures 
With a median follow-up of 39 months (range 
17-101 months), eight (18%) patients had relapse: five 
(10%) locoregional, and four (8%) distant. Nine pa-
tients had died. The 3-year overall survival was 85%, 
the locoregional control survival was 89%, and distant 
metastasis-free survival was 92%. A total of 19 pa-
tients (40%) in this series were found to have Twist 
over-expression. Twist over-expression demonstrated 
worse overall survival rates compared with others. 
The 3-year overall survival was 96% in patients with 
negative Twist expression and 72% in patients with 
Twist over-expression (P = 0.01; Figure 3A). There 
was no significant difference in distant metastasis-free 
survival in NPC patients with Twist over-expression 
(P = 0.126, Figure 3B). The receiver operating char-
acteristic (ROC) curves (Figure 4) for predicting out-
comes revealed that Twist expression (area under 
curve = 0.735) was superior to T classification (area 
under curve = 0.718) and clinical stage (area under 
curve = 0.598). Patients with positive expression of 
TWIST showed a significantly increased rate of dis-
tant metastasis and overall mortality, which is noted in 
Table 3. 
A summary of hazard ratios for the classification 
of TNM staging system, age, gender and Twist ex-
pression were listed in Table 4. Twist over-expression 
and T classification were the significant prognostic 
factors during univariate analysis (P = 0.024, and 
0.043 respectively). In multivariate analysis, Twist 
overexpression remained an independent prognostic 
factor [hazard ratio (HR) 5, 95% confidence interval 
(CI) 1.07-27; P = 0.041], but the T classification be-
came insignificant (HR 3, 95% CI 0.8-14; P = 0.086). 
In this series, there was no statistically significant 
prognostic factor in distant metastasis (Table 2) and 
local recurrence (data not shown).  
 
DISCUSSION 
 
Synopsis of Key/New Findings 
Nasopharyngeal carcinoma is notorious for its 
highly metastatic property in head and neck cancers.  
M. S. Lee et al./JCRP 1(2014) 186-196 191
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Immunohistochemical analysis of Twist protein using polyclonal anti-Twist (H-81) antibody in naso-
pharyngeal carcinoma (NPC) tissues. (A) Negative staining of Twist protein in NPC cells (×400). (B) 
Positive staining of Twist protein in NPC cell (×400). The nuclei were counterstained by hematoxylin 
 
 
Although NPC is highly sensitive to chemoradiother-
apy, recurrent or residual disease and distant metasta-
sis conferred a poor prognosis. Besides using the pre-
sent TNM staging system, some novel prognostic fac-
tors are necessary.  
Using immunohistochemical method, 19 of 48 
(40%) NPC patients were graded as positive Twist 
expression in our study, which was consistent with the 
reports by Song et al [13]. The presence of positive 
Twist in NPC patients significantly conferred a poor 
survival rate (HR 5, P = 0.041) in multivariate analy-
sis. The receiver operating characteristic (ROC) 
curves also documented the superiority of Twist 
over-expression in prediction of survival outcome 
over traditional T classification and clinical stage.  
Positive Twist expression was associated with 
prevertebral space invasion, which is a novel negative 
prognostic factor in NPC during multivariate model 
[4]. Although the relationship between Twist and me-
tastasis-free survival was not significant, this conclu-
sion may in part be due to the short-term follow up 
and insufficient event. More locally advanced disease, 
while initial diagnoses might indicate the aggressive 
nature of disease, could be the major contributor of 
poor survival outcome.  
Strength of This Study 
First, expression of Twist protein plays an im-
portant role in disease resolution of nasopharyngeal 
carcinoma. By in-vitro cell line of nasopharyngeal 
carcinoma, we documented the association between 
Twist protein and marker of epithelial- mensenchymal 
transition. 
Second, in grading the expression of Twist protein 
in NPC tissue, both the percentage of positive cells 
and staining intensity are considered in this series. The 
staining intensity was scored as 0 (negative), 1(1+), 2 
(2+) or 3 (3+), and the percentage of positive cells as 
0 (0%), 1 (<25%), 2 (25-50%), 3 (>50%). The case 
was interpreted as positive if the value of percentage 
positive score multiplied by intensity score was more 
than 3. Compared with other studies which used only 
percentage of positive cells or staining intensity, the 
grading method in our series was more comprehensive 
[10]. 
Third, previous studies revealed the prognostic in-
fluence of Twist in univariate analysis. We further 
conducted a multivariate analysis to reveal that Twist 
over-expression was an independent prognostic factor 
in NPC which was not proven previously. 
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Figure 3. (A) Effect of Twist expression on overall survival rates of nasopharyngeal carcinoma (NPC) patients.   
(B) Effect of Twist expression on metastasis-free survival of NPC patients 
 
 
Comparisons with Other Studies 
Latent membrane protein-1 (LMP-1) in NPC tis-
sue activates nuclear factor-κB which further induced 
expression of Twist. Up-regulation of Twist is associ-
ated with epithelial-mesenchymal transition [12].  
Epithelial-mesenchymal transition (EMT) was a key 
step in cancer metastasis and tumor invasion [14]. 
Upon loss of epithelial cell adhesion and cytoskeletal 
components, cells acquire mesenchymal characteris-
tics and possess a migratory phenotype and higher 
resistance to cytotoxic agent. Suppression of Twist 
expression with small interfering RNA in highly met-
astatic mammary carcinoma specifically inhibits me-
tastasis from the mammary glands to the lung [11]. 
Using retroviral infection, ectopic expression of Twist 
results in loss of E-cadherin-mediated cell-cell adhe-
sion, activation of mesenchymal markers, and en-
hancement of cell motility. Down-regulation of Twist 
through small interfering RNA suppressed migration 
and the invasion ability of mammary carcinoma cells. 
Decreased Twist expression is associated with induc-
tion of E-cadherin expression and mesenchymal to 
epithelial transition in prostate cancer cells [15]. 
Twist over-expression has been reported in several 
cancers. Over-expression of Twist inhibits apoptosis 
in rhabdomyosarcoma, which arises from skeletal 
muscle precursors that fail to differentiate [16]. Twist 
is upregulated in esophageal squamous cell carcinoma 
cell lines, and high level of Twist expression in pa-
tients with esophageal squamous cell carcinoma is 
significantly associated with distant metastasis within 
one year of esophagectomy [10]. Twist is elevated in 
tumor tissues (both in intensity of immunohistochem-
ical staining and in quatitative polymerase chain reac-
tion) with increasing nodal involvement and associat-
ed with disease-specific death in breast cancer [7].  
Up-regulation of Twist has been noted in naso-
pharyngeal carcinoma. Song et al [13]. mentioned 
poor prognosis of Twist expression, no matter whether 
it was determined by immunohistochemistry stain, in 
situ hybridization, or reverse-transcription-polymerase 
chain reaction. In our study, we chose the easily-obtained  
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and practical method and further used the stringent 
criteria of so-called positive Twist by immunohisto-
chemistry stain. The result of prognostic impact was 
similar between the two studies. Moreover, we ex-
plored the relationship between Twist and pre-vertebral 
space invasion, and documented priority of Twist over 
commonly-used traditional classification. Furthermore, 
previous studies only report prognostic impact with 
univariate analysis. Our study first reported the inde-
pendent prognostic influence of Twist in nasopharyn-
geal carcinoma in multivariate analysis. 
 
Limitation of Our Study 
There are some limitations to the current study. 
First, the interpretation of Twist expression was made 
under light microscope, and perhaps a computer-  
assisted analysis may improve the objectiveness of 
expression assessment. Second, there is no consensus 
in the definition of Twist overexpression. Some 
authors have evaluated the percentage of positive cells 
only, and some authors used both the intensity score 
and percentage of positive cells. We used the method 
that was introduced by Yuen et al [10]. Third, the fol-
low-up period was too short, and the available event 
was insufficient. Even though there were a limited 
number of events, the expression of Twist showed 
significant correlation with poor survival outcome and 
trend toward advanced disease nature. Fourth, the case 
numbers were not large. However, our result revealed 
that Twist was an independently prognostic factor in 
nasopharyngeal carcinoma. Five, there was a lack of 
data to explore the correlation between immunohisto-
chemistry stain and in situ hybridization or reverse- 
transcription-polymerase chain reaction of Twist, alt-
hough it had been proven by Song et al [13]. 
 
Table 4. Univariate and multivariate analysis of different prognostic factors in NPC patients (n=48) 
Clinical endpoint Variable Unadjusted HR 
(95% CI) 
P value  Adjusted HR 
(95% CI)* 
P value 
Overall survival Twist positive/ Twist 
negative 
6 (1.3-30) 0.024  5 (1.07-27) 0.041 
 T3-4/T1-2 4 (1.05-17) 0.043  3 (0.8-14) 0.086 
 N2-3/N0-1 2 (0.4-6) 0.546    
 Age 1 (0.97-1.04) 0.403    
 Male/Female 39 (0.1-132) 0.219    
 CCRT+CT/ RT or 
CCRT 
0.8 (0.2-3) 0.706    
Distant metastasis Twist positive/ Twist 
negative 
5 (0.5-48) 0.167    
 T3-4/T1-2 2 (0.3-15) 0.452    
 N2-3/N0-1 3 (0.3-32) 0.299    
 Age 1 (0.87-1.07) 0.464    
 Male/Female 40 (0.007-233) 0.403    
 CCRT+CT/ RT or 
CCRT 
0.6 (0.06-5) 0.605    
HR, hazard ratio; 95% CI, 95% confidence interval 
*Variable with a p-value<0.05 during univariate analysis were included in adjusted model 
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Figure 4. Receiver operating characteristic curves by 
Twist expression, T classification, and 
clinical stage 
 
 
Aspect of Further Studies 
Further prospective studies and long-term fol-
low-up are needed to confirm the role of immuno-
histochemistry stain of Twist in clinical practice.  
Furthermore, hypoxia inducible factor-1α (HIF-1α) 
directly regulate Twist expression [9], which also is 
highly expressed in nasopharyngeal carcinoma. Cur-
rently, many novel targeted therapies, just like heat 
shock protein 90(Hsp90) inhibitor, are been investi-
gated to target HIF-1α. Patients with nasopharyngeal 
carcinoma should be the potential beneficiaries of 
such additional therapies. 
The mechanism of epithelial-mesenchymal transi-
tion had been explored and the transcription factors, 
such as Slug, Snai1, and Twist, have been documented 
to play an important role in EMT. Dyssynchronization 
of Twist and Snai1expression in stroma and tumor cell 
supported the hypothesis of reprogramming of tumor 
cell into fibroblasts. Horikawa et al [17]. described 
that a pivotal role for Snai1 might exist in EMT of 
NPC. Further investigation about the correlation of 
Twist and Snai1 in patients with nasopharyngeal car-
cinoma might be helpful in predict outcome. 
 
Clinical Applicability of the Study 
Our study revealed that Twist may be a useful 
molecular marker for nasopharyngeal carcinoma and 
indicator for overall survival and distant metastasis. 
Additionally, the method of immunohistochemistry 
stain of Twist is tremendously practical and easily 
obtained. Therefore, it is feasible to be applied in 
clinical practice. In multivariate analysis, Twist ex-
pression was an independently prognostic factor in 
NPC. Patients with Twist expression should be treated 
more aggressively and clinical trials should be initiat-
ed earlier to explore the treatment results with differ-
ent treatment modalities in regards to Twist expres-
sion. Furthermore, regarding patient pathophysiology, 
it could be the potential target of treatment in the fu-
ture. 
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